Ermium Therapeutics

About:

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.

Website: https://www.ermium.com/

Top Investors: Eurazeo, Domain Therapeutics, Kurma Partners, Idinvest Partners, Fountain Healthcare Partners

Description:

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation. Ermium Therapeutics was founded in June 2019 by Jean-Philippe HERBEUVAL, Kurma Partners, Idinvest Partners, Domain Therapeutics and Erganeo. The company is based in Paris and has signed a worldwide exclusive license agreement on intellectual property from CNRS and University Paris Descartes (France) through an agreement with Erganeo, which supported the maturation of the project in an academic setting. In addition, Ermium Therapeutics recently won the innovation i-Lab 2019 award from the French Ministry of Research and Higher Education.